Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
Monoclonal antibodies (mAb) are revolutionising the treatment of many different diseases. Given their differing mode of action compared to most conventional chemotherapeutics and small molecule inhibitors, they possess the potential to be independent of common modes of treatment resistance and can t...
Main Authors: | , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer US
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891381/ |